NUI Galway Hosts Transatlantic Think-Tank on Stem Cell and Gene Therapy

Wednesday, 5 July 2006

The Regenerative Medicine Institute (REMEDI) will host a 'Conference in Regenerative Medicine' at NUI Galway, in conjunction with US academic partners Georgia Tech and the Mayo Clinic, from 11-12 July. The conference will feature over twenty speakers advancing the latest thinking and developments in orthopaedic, neurological and cardiovascular regenerative medicine.

Regenerative medicine approaches the repair or replacement of tissues and organs by incorporating the use of cells and genes to regenerate healthy tissues. Themes addressed at the event will include cellular therapy, gene therapy, biomaterials science, immunology and tissue engineering.

"One of the central elements of this new technology is the transplantation of stem cells for the repair or regeneration of tissues damaged by trauma or disease. Progress in this field is dependent upon close alliances between scientists, clinicians and engineers. Our conference will seek to advance these research ties and expand our shared knowledge base", commented Frank Barry, REMEDI Scientific Director.

NUI Galway has worked closely for many years with Georgia Tech, which recently opened its first applied research facility outside the United States in Athlone, Co. Westmeath. Professor Anthony Windebank, leading expert in regeneration of the nervous system at the prestigious Mayo Clinic is currently based at REMEDI as part of a Science Foundation Ireland E.T.S Walton Fellowship.

REMEDI Director, and Chair of Medicine at NUI Galway, Timothy O'Brien, commented, "This conference comes just weeks after the Irish government announced its Strategy for Science, Technology and Innovation. The strategy points out that Ireland must underpin its lead in the biotechnology arena and we seek to advance this by forging ever stronger links with our US counterparts such as Georgia Tech and the Mayo Clinic."

The conference runs from 11-12 July and will be attended by representatives from US and Irish universities, industry partners and government agencies.

-ends-

Notes to editors: The Regenerative Medicine Institute (REMEDI) is a world-class biomedical research centre focusing on gene therapy and stem cell research. In state-of-the-art facilities, researchers at REMEDI work together to combine the technologies of gene therapy and adult stem cell therapy with the aim of regeneration and repair of tissues. The unique feature of the research carried out at REMEDI is the novel integration of both therapies in a complementary research and development programme.

Based in the National University of Ireland, Galway, REMEDI was established in 2003 through a Science Foundation Ireland (SFI) Centre for Science Engineering and Technology (CSET) award, and industry funding. The institute is located at the National Centre for Biomedical Engineering Science and incorporates the National Cell and Gene Vector Laboratory, a GMP grade vector and cell production facility.

REMEDI is a partnership involving scientists, clinicians, and engineers in academic centres and in industry. It is a unique cluster of talented and committed individuals who share a vision in developing new and successful treatment options for patients.

For further information contact: Ita Murphy MSc Communications and Outreach Manager Regenerative Medicine Institute (REMEDI) & National Centre for Biomedical Engineering Science (NCBES) National University of Ireland Galway Phone: +353 (0)91 495198 Mobile: Phone: +353 (0)91 495198 Email: ita.murphy@nuigalway.ie

« Back